Chemoinformaics analysis of Isobutyric acid, tridecyl ester
| Molecular Weight | 270.457 | nRot | 13 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 1 |
| Exact Molecular Weight | 270.256 | nRing | 0 |
| Solubility: LogS | -6.64 | nHRing | 0 |
| Solubility: LogP | 7.01 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 52.665 |
| nHD | 0 | BPOL | 36.713 |
| QED | 0.326 |
| Synth | 1.885 |
| Natural Product Likeliness | 0.298 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.026 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.707 |
| MDCK | 0.0000162 |
| BBB | 0.238 |
| PPB | 0.973968 |
| VDSS | 1.517 |
| FU | 0.0224478 |
| CYP1A2-inh | 0.428 |
| CYP1A2-sub | 0.209 |
| CYP2c19-inh | 0.518 |
| CYP2c19-sub | 0.155 |
| CYP2c9-inh | 0.275 |
| CYP2c9-sub | 0.891 |
| CYP2d6-inh | 0.105 |
| CYP2d6-sub | 0.077 |
| CYP3a4-inh | 0.317 |
| CYP3a4-sub | 0.111 |
| CL | 4.435 |
| T12 | 0.15 |
| hERG | 0.223 |
| Ames | 0.005 |
| ROA | 0.042 |
| SkinSen | 0.93 |
| Carcinogencity | 0.075 |
| EI | 0.981 |
| Respiratory | 0.751 |
| NR-Aromatase | 0.062 |
| Antiviral | Yes |
| Prediction | 0.669845 |